$85.05
+ $1.09 (1.30%)
End-of-day quote: 05/31/2024
NasdaqGM:LGND

Ligand Pharmaceuticals Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$131.31M $196.25M $241.54M $186.42M $120.28M $251.45M $141.10M $108.97M $71.91M $64.54M $48.97M $31.39M $30.04M $23.54M $38.94M $27.32M $12.89M $3.98M $10.22M $80.77M
GM % Gross Margin %
73.31% 54.69% 60.97% 51.82% 44.09% 86.40% 77.14% 75.41% 76.62% 70.74% 69.36% 54.15% 49.40% 6.25% 45.57% 100.00% 100.00% 50.52% 100.00% 77.39%
OM Operating Margin
7.48% 1.55% 27.43% 15.79% -4.76% 65.11% 48.25% 40.27% 38.00% 32.09% 32.64% 3.87% 0.85% -48.25% -41.45% -99.73% 0.00% 0.00% 0.00% -57.85%
EPS Earnings Per Share
$0.00 $6.09 $4.79 $6.42 $4.55 $3.09 $7.15 $3.26 $3.33 $3.37 $1.52 $0.90 $-0.12 $0.63 $0.18 $0.30 $-1.62 $17.22 $6.00 $-2.94 $-3.66
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0.00% 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
17.56m 16.95m 16.77m 16.08m 16.82m 20.77m 21.15m 20.91m 19.95m 19.58m 20.47m 20.16m 19.56m 19.51m 19.56m 18.83m 15.88m 16.75m 12.34m 12.32m
OCF Operating Cash Flow
$49.58M $137.85M $78.80M $54.59M $-29.34M $194.06M $88.57M $60.73M $41.73M $20.57M $20.69M $0.16M $-1.17M $-27.07M $-33.80M $-20.63M $-97.73M $-138.52M $8.37M $5.75M
FCF Free Cash Flow
$41.77M $119.93M $70.04M $50.13M $-31.89M $193.17M $91.41M $61.15M $41.63M $20.56M $20.31M $-0.44M $-1.25M $-27.14M $-34.32M $-21.13M $-98.17M $-140.30M $5.77M $2.15M
FCFS Free Cash Flow Per Share
$-0.22 $7.12 $4.24 $3.18 $41.11 $8.66 $4.44 $1.98 $1.90 $0.96 $0.82 $-0.02 $-0.06 $-1.45 $-1.82 $-1.33 $-6.00 $-10.44 $0.47 $0.18